CytoDel, INC. — Form D
CytoDel, INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-17. The offering totals $6.1M, of which $3.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-01-17
- Form: D
- Accession: 0001705194-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.1M
- Amount sold: $3.9M
- Remaining: $2.2M
- Minimum investment: $50K
- Investors: 11
- Date of first sale: 2018-01-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-303381
Issuer
- Name: CytoDel, INC.
- CIK: 0001705194
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 423 WEST 127TH STREET, NEW YORK, NY, 10027
- Phone: 646-820-0066
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Philip A Band | Director | New York, NY |
| Margery A Fischbein | Director | New York, NY |
| Andre A Gudger | Director | New York, NY |
| Charles A Weiss | Director | New York, NY |
| Philip A Band | Executive Officer | New York, NY |
Other filings by this issuer (1)
More